Literature DB >> 17034613

Effects of ovariectomy and oestrogen replacement on the function and expression of Rho-kinase in rat bladder smooth muscle.

Sung K Hong1, Ji H Yang, Tae B Kim, Soo W Kim, Jae-Seung Paick.   

Abstract

OBJECTIVE: To investigate the effects of ovariectomy and oestrogen replacement on the function and expression of Rho-kinase in rat bladder smooth muscle, as the actual effects of oestrogen deprivation on bladder smooth muscle are unclear.
MATERIALS AND METHODS: Female Sprague-Dawley rats were placed into one of three groups: sham-operated, bilateral ovariectomy-only, and bilateral ovariectomy plus oestrogen replacement groups. In the last group, oestrogen was replaced by weekly injection of beta-estradiol 17-cypionate (250 microg/kg subcutaneously for 6 weeks) beginning at 1 week after ovariectomy, whereas the other groups received vehicle-only injections for 6 weeks. After treatment, the bladder was removed for muscle strip studies to evaluate the effects of Y-27632, a specific inhibitor of Rho-kinase, on baseline tension and carbachol-induced tonic contractions. Also, the protein expression of RhoA and Rho-kinase isoenzymes was assessed by Western blot analysis.
RESULTS: Of the three groups, incubation with 10 microm Y-27632 resulted in the largest decrease in baseline tension of strips from the bilateral ovariectomy-only group, but this was not statistically significant (P > 0.05). For carbachol-induced tonic contractions, strips from the bilateral ovariectomy-only group were attenuated the most among the three groups after adding Y-27632 (P < 0.05). However, there were no significant differences in the levels of RhoA and the two Rho-kinase isoenzymes in bladder tissues from the three groups.
CONCLUSION: Our data show that oestrogen might inhibit the function of Rho-kinase in bladder smooth muscle, while having no significant effect on its expression. This finding might help to explain the greater incidence of urinary tract symptoms suggestive of overactive bladder after the menopause in women.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17034613     DOI: 10.1111/j.1464-410X.2006.06486.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  5 in total

1.  The effect of L-arginine on bladder dysfunction following ovariectomy in a rabbit model.

Authors:  Shu-Mien Chuang; Yung-Shun Juan; Cheng-Yu Long; Chun-Hsiung Huang; Robert M Levin; Keh-Min Liu
Journal:  Int Urogynecol J       Date:  2011-06-10       Impact factor: 2.894

2.  Effects of vaginal conjugated equine estrogens and ospemifene on the rat vaginal wall and lower urinary tract.

Authors:  P Antonio Maldonado; T Ignacio Montoya; Jesus F Acevedo; Patrick W Keller; R Ann Word
Journal:  Biol Reprod       Date:  2017-01-01       Impact factor: 4.285

3.  Effects of 4-vinylcyclohexene diepoxide on peripubertal and adult Sprague-Dawley rats: ovarian, clinical, and pathologic outcomes.

Authors:  F Salih Muhammad; Amanda K Goode; Nancy D Kock; Esther A Arifin; J Mark Cline; Michael R Adams; Patricia B Hoyer; Patricia J Christian; Scott Isom; Jay R Kaplan; Susan E Appt
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

4.  Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone.

Authors:  Noriyuki Homma; Tetsutaro Nagaoka; Vijaya Karoor; Masatoshi Imamura; Laimute Taraseviciene-Stewart; Lori A Walker; Karen A Fagan; Ivan F McMurtry; Masahiko Oka
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-09       Impact factor: 5.464

5.  Comparative pharmacological analysis of Rho-kinase inhibitors and identification of molecular components of Ca2+ sensitization in the rat lower urinary tract.

Authors:  Cleber E Teixeira; Liming Jin; Fernanda B M Priviero; Zhekang Ying; R Clinton Webb
Journal:  Biochem Pharmacol       Date:  2007-06-07       Impact factor: 5.858

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.